Search Results

There are 19139 results for: content related to: Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. You have free access to this content
    Methotrexate (MTX)–cIBR conjugate for targeting MTX to leukocytes: Conjugate stability and in vivo efficacy in suppressing rheumatoid arthritis

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 9, September 2012, Pages: 3275–3291, Sumit Majumdar, Meagan E. Anderson, Christine R. Xu, Tatyana V. Yakovleva, Leo C. Gu, Thomas R. Malefyt and Teruna J. Siahaan

    Version of Record online : 26 APR 2012, DOI: 10.1002/jps.23164

  5. Analysis of the interacting surface of maurotoxin with the voltage-gated Shaker B K+ channel

    Journal of Peptide Science

    Volume 17, Issue 3, March 2011, Pages: 200–210, Ziad Fajloun, Nicolas Andreotti, Mohamed Fathallah, Jean-Marc Sabatier and Michel De Waard

    Version of Record online : 11 JAN 2011, DOI: 10.1002/psc.1313

  6. You have free access to this content
    Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK

    Arthritis & Rheumatism

    Volume 63, Issue 9, September 2011, Pages: 2606–2616, Charles F. Spurlock III, Zachary T. Aune, John T. Tossberg, Patrick L. Collins, Jessica P. Aune, Joseph W. Huston III, Philip S. Crooke, Nancy J. Olsen and Thomas M. Aune

    Version of Record online : 31 AUG 2011, DOI: 10.1002/art.30457

  7. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell and George A Wells

    Published Online : 8 MAY 2017, DOI: 10.1002/14651858.CD012657

  8. You have free access to this content
    Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  9. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell and George A Wells

    Published Online : 17 NOV 2016, DOI: 10.1002/14651858.CD012437

  10. You have free access to this content
    Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 65, Issue 2, February 2013, Pages: 334–342, Mary Chester M. Wasko, Abhijit Dasgupta, Helen Hubert, James F. Fries and Michael M. Ward

    Version of Record online : 28 JAN 2013, DOI: 10.1002/art.37723

    Corrected by:

    Errata: Error in Text Regarding Body Mass Index and Survival in the Article by Wasko et al (Arthritis Rheum, February 2013)

    Vol. 65, Issue 5, 1231, Version of Record online: 23 APR 2013

  11. You have free access to this content
    The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ranging Study

    Arthritis & Rheumatology

    Volume 67, Issue 10, October 2015, Pages: 2591–2600, Michael E. Weinblatt, Philip Mease, Eduardo Mysler, Tsutomu Takeuchi, Edit Drescher, Alberto Berman, Jun Xing, Moshe Zilberstein, Subhashis Banerjee and Paul Emery

    Version of Record online : 23 SEP 2015, DOI: 10.1002/art.39249

  12. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss

    Journal of Cellular Physiology

    Volume 227, Issue 7, July 2012, Pages: 2889–2897, Tetyana Shandala, Yeap Shen Ng, Blair Hopwood, Yuen-Ching Yip, Bruce K. Foster and Cory J. Xian

    Version of Record online : 20 MAR 2012, DOI: 10.1002/jcp.23034

  13. You have free access to this content
    ACR/ARHP scientific abstracts

    Arthritis & Rheumatism

    Volume 42, Issue S9, September 1999, Pages: S71–S407,

    Version of Record online : 9 MAY 2012, DOI: 10.1002/art.1780422107

  14. Fostamatinib, a Syk-Kinase Inhibitor, Does Not Affect Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 51, Issue 9, September 2011, Pages: 1310–1318, Dr Muhammad Baluom, Dr Emil Samara, Dr Elliott B. Grossbard and Dr David T.-W. Lau

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010381496

  15. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Wanruchada Katchamart, Judith Trudeau, Veerapong Phumethum and Claire Bombardier

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD008495

  16. You have free access to this content
    Characterization of the maitotoxin-activated cationic current from human skin fibroblasts

    The Journal of Physiology

    Volume 538, Issue 1, January 2002, Pages: 79–86, Juan Ramón Martínez-François, Verónica Morales-Tlalpan and Luis Vaca

    Version of Record online : 22 JUL 2004, DOI: 10.1113/jphysiol.2001.013036

  17. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid

    British Journal of Dermatology

    Volume 161, Issue 4, October 2009, Pages: 723–731, H.M. Gürcan and A. Razzaque Ahmed

    Version of Record online : 22 APR 2009, DOI: 10.1111/j.1365-2133.2009.09246.x

  18. You have free access to this content
    Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 329–342, Isabelle Benz-de Bretagne, Noël Zahr, Amélie Le Gouge, Jean-Sébastien Hulot, Caroline Houillier, Khe Hoang-Xuan, Emmanuel Gyan, Séverine Lissandre, Sylvain Choquet and Chantal Le Guellec

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12326

  19. You have free access to this content
    Methotrexate increases expression of cell cycle checkpoint genes via JNK activation

    Arthritis & Rheumatism

    Volume 64, Issue 6, June 2012, Pages: 1780–1789, Charles F. Spurlock III, John T. Tossberg, Howard A. Fuchs, Nancy J. Olsen and Thomas M. Aune

    Version of Record online : 25 MAY 2012, DOI: 10.1002/art.34342

  20. Leflunomide for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Manathip Osiri, Beverley Shea, Vivian Welch, Maria E Suarez-Almazor, Vibeke Strand, Peter Tugwell and George A Wells

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD002047